Who
Douglas A. Michels
Director
Company insider
Files Form 4 as: Director, West Pharmaceutical Services; Director, Tyme Technologies; President & CEO, OraSure Technologies.
In numbers
- Trades disclosed
- 243
- Buys
- 2
- Sells
- 18
- Bought
- $113K
- Sold
- $23.4M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 31 Dec 2005
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —1,071 at $0.00 | filing |
| 23 Apr 2024filed 25 Apr 2024 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —564 at $0.00 | filing |
| 25 Apr 2023filed 27 Apr 2023 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —616 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code D | —45,833 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code D | —100,000 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code D | —50,000 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code D | —65,000 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code D | —88,000 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code D | —88,000 | filing |
| 16 Sep 2022filed 16 Sep 2022 | Tyme Technologies | SEC FORM 4 Code D | —110,000 | filing |
| 24 Aug 2022filed 29 Aug 2022 | Tyme Technologiesoption or derivative | SEC FORM 4 Code A | —88,000 at $0.00 | filing |
| 24 May 2022filed 26 May 2022 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —632 | filing |
| 24 Aug 2021filed 26 Aug 2021 | Tyme Technologiesoption or derivative | SEC FORM 4 Code A | —88,000 at $0.00 | filing |
| 4 May 2021filed 6 May 2021 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —577 | filing |
| 1 Sep 2020filed 3 Sep 2020 | Tyme Technologies | SEC FORM 4 Bought | $48K50,000 at $0.96 | filing |
| 20 Aug 2020filed 24 Aug 2020 | Tyme Technologiesoption or derivative | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 5 May 2020filed 7 May 2020 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —975 | filing |
| 22 Aug 2019filed 27 Aug 2019 | Tyme Technologiesoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
LENSAR (NASDAQ:LNSR) and OraSure Technologies (NASDAQ:OSUR) Critical ComparisonOSUR · tickerreport.com · 21 Oct 2026Critical Analysis: electroCore (NASDAQ:ECOR) & OraSure Technologies (NASDAQ:OSUR)OSUR · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Douglas A. Michels; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.